604000-34-2

Basic information

• Product Name: 3,6-Pyridazinedicarboxylic acid 3-ethyl ester
• Synonyms: 3,6-Pyridazinedicarboxylic acid 3-ethyl ester;6-(ethoxycarbonyl)pyridazine-3-carboxylic acid
• CAS NO: 604000-34-2
• Molecular Formula: C8H8N2O4
• Molecular Weight: 196.16012
• EINECS: -0
• Mol File: 604000-34-2.mol

Chemical Properties

• Boiling Point: 445.0±30.0 °C(Predicted)
• Appearance: /
• Density: 1.373±0.06 g/cm3(Predicted)
• PKA: 2.50±0.10(Predicted)
• CAS DataBase Reference: 3,6-Pyridazinedicarboxylic acid 3-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3,6-Pyridazinedicarboxylic acid 3-ethyl ester(604000-34-2)
• EPA Substance Registry System: 3,6-Pyridazinedicarboxylic acid 3-ethyl ester(604000-34-2)

Safety Data

• Hazardous Substances Data: 604000-34-2(Hazardous Substances Data)

Upstream product

• 113631-50-8 3,6-Dicarboethoxypyridazine 

Relevant articles and documents

SULFONAMIDE COMPOUND OR SALT THEREOF

[Object] A compound which is useful as an EP1 receptor antagonist is provided. [Means for Solution] The present inventors investigated EP1 receptor antagonists, and confirmed that a compound having a sulfonamide structure, in which the nitrogen atom of the sulfonamide structure is substituted with 2-fluoropropyl group, 3-fluoro-2-methylpropyl group or the like, has a potent EP1 receptor antagonistic action, thereby completing the present invention. The sulfonamide compound of the present invention has a potent EP 1 receptor antagonistic action and can be used as an agent for preventing and/or treating a lower urinary tract symptom or the like.

CONDENSED HETEROCYCLIC COMPOUNDS AS CALCITONIN AGONISTS

The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions which are related to irregular calcification.